Cargando…
Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient
Autores principales: | Busutti, Marco, Cingolani, Alessandra, Natali, Filippo, Mattiotti, Maria, Grandinetti, Valeria, Baraldi, Olga, Comai, Giorgia, Candoli, Piero, La Manna, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919162/ https://www.ncbi.nlm.nih.gov/pubmed/35286598 http://dx.doi.org/10.1007/s40620-022-01298-w |
Ejemplares similares
-
Nodular subcutaneous infiltrates in a kidney transplant recipient: lessons from a case
por: Kolland, Michael, et al.
Publicado: (2022) -
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021) -
Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis
por: Castellano, Giuseppe, et al.
Publicado: (2020) -
Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist
por: Uwatoko, Ryuta, et al.
Publicado: (2023) -
Lessons for the clinical nephrologist: recurrence of nephrotic syndrome induced by SARS-CoV-2
por: Doevelaar, Adrian A. N., et al.
Publicado: (2020)